These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Perspective--Part II: radiotherapy for Graves Orbitopathy: the Columbia University experience. Kazim M Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):173-4. PubMed ID: 12021645 [No Abstract] [Full Text] [Related]
7. The use of corticosteroids versus other treatments for Graves' ophthalmopathy: a quantitative evaluation. Abalkhail S; Doi SA; Al-Shoumer KA Med Sci Monit; 2003 Nov; 9(11):CR477-83. PubMed ID: 14586273 [TBL] [Abstract][Full Text] [Related]
8. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment]. Kamoun M; Abid H; Lamine F; Slimane H; Haddad A Tunis Med; 2003 Mar; 81(3):149-55. PubMed ID: 12793063 [TBL] [Abstract][Full Text] [Related]
9. Radiotherapy in thyroid eye disease: the effect on the field of binocular single vision. Ferris JD; Dawson EL; Plowman N; Adams GG; Fells P; Lee JP J AAPOS; 2002 Apr; 6(2):71-6. PubMed ID: 11997801 [TBL] [Abstract][Full Text] [Related]
10. Controversy in thyroid disease. Bydder S J R Coll Physicians Lond; 2000; 34(6):586; author reply 587. PubMed ID: 11191981 [No Abstract] [Full Text] [Related]
11. [Radiotherapy of endocrine orbitopathy--state of the art]. Prettenhofer U; Ramschak-Schwarzer S; Langmann A; Mayer R; Schedlbauer P; Hackl A Acta Med Austriaca; 2001; 28(4):97-8. PubMed ID: 11593899 [TBL] [Abstract][Full Text] [Related]
12. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence. Wei RL; Cheng JW; Cai JP Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177 [TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging in diagnosis and follow-up of minimal thyroid ophthalmopathy. Matsuo H; Motomura M; Takeo G; Yoshimura T; Tsujihata M; Nagataki S Jpn J Med; 1991; 30(3):229-32. PubMed ID: 1920963 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids]. Brauer VF; Scholz GH Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657 [TBL] [Abstract][Full Text] [Related]
15. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids. Bednarek J; Wysocki H; Sowiński J Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621 [TBL] [Abstract][Full Text] [Related]
17. [Thyroid orbitopathy, an overview with special attention to the role of radiotherapy]. Vilar-González S; Lamas-Oliveira C; Fagúndez-Vargas MA; Núñez-Quintanilla AT; Pérez-Rozos A; Merayo-Lloves J; Escobar-Barranco JJ; Rico-Pérez JM Endocrinol Nutr; 2015 Apr; 62(4):188-99. PubMed ID: 25637365 [TBL] [Abstract][Full Text] [Related]
18. Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. El-Kaissi S; Frauman AG; Wall JR Intern Med J; 2004 Aug; 34(8):482-91. PubMed ID: 15317547 [TBL] [Abstract][Full Text] [Related]
19. Does radiotherapy have a role in the management of thyroid orbitopathy? View 2. Mourits MP Br J Ophthalmol; 2002 Jan; 86(1):104-6. PubMed ID: 11806399 [No Abstract] [Full Text] [Related]
20. Torsional diplopia in Graves' orbitopathy. Three case reports. Vandelanotte S; De Clippeleir L; Dieltiens M; Van Lammeren M Bull Soc Belge Ophtalmol; 2003; (288):33-9. PubMed ID: 12879723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]